174 related articles for article (PubMed ID: 2827490)
1. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
[TBL] [Abstract][Full Text] [Related]
2. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
3. Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene.
Stefaneanu L; Rindi G; Horvath E; Murphy D; Polak JM; Kovacs K
Endocrinology; 1992 Apr; 130(4):1789-95. PubMed ID: 1312426
[TBL] [Abstract][Full Text] [Related]
4. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
Hanahan D
Nature; 1985 May 9-15; 315(6015):115-22. PubMed ID: 2986015
[TBL] [Abstract][Full Text] [Related]
5. Morphological study of pituitary tumorigenesis in transgenic mice induced by hybrid oncogene of the thyrotropin beta-subunit and the simian virus 40 large T-antigen.
Kon Y; Miyoshi I; Maki K; Yamashita T; Aoyama S; Watanabe T; Hayashizaki Y; Kasai N
Histol Histopathol; 1997 Oct; 12(4):981-90. PubMed ID: 9302559
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
7. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
8. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.
Efrat S; Linde S; Kofod H; Spector D; Delannoy M; Grant S; Hanahan D; Baekkeskov S
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9037-41. PubMed ID: 2848253
[TBL] [Abstract][Full Text] [Related]
9. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice.
Windle JJ; Weiner RI; Mellon PL
Mol Endocrinol; 1990 Apr; 4(4):597-603. PubMed ID: 1704103
[TBL] [Abstract][Full Text] [Related]
10. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
11. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice.
Maki K; Miyoshi I; Kon Y; Yamashita T; Sasaki N; Aoyama S; Takahashi E; Namioka S; Hayashizaki Y; Kasai N
Mol Cell Endocrinol; 1994 Nov; 105(2):147-54. PubMed ID: 7859921
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.
Bale AE; Norton JA; Wong EL; Fryburg JS; Maton PN; Oldfield EH; Streeten E; Aurbach GD; Brandi ML; Friedman E
Cancer Res; 1991 Feb; 51(4):1154-7. PubMed ID: 1671755
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
Fielitz K; Althoff K; De Preter K; Nonnekens J; Ohli J; Elges S; Hartmann W; Klöppel G; Knösel T; Schulte M; Klein-Hitpass L; Beisser D; Reis H; Eyking A; Cario E; Schulte JH; Schramm A; Schüller U
Oncotarget; 2016 Nov; 7(46):74415-74426. PubMed ID: 27769070
[TBL] [Abstract][Full Text] [Related]
14. Neural tissue within anterior pituitary tumors generated by oncogene expression in transgenic mice.
Schechter J; Windle JJ; Stauber C; Mellon PL
Neuroendocrinology; 1992 Sep; 56(3):300-11. PubMed ID: 1331836
[TBL] [Abstract][Full Text] [Related]
15. Role of the amino-terminal domain of simian virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice.
Ratineau C; Ronco A; Leiter AB
Gastroenterology; 2000 Nov; 119(5):1305-11. PubMed ID: 11054388
[TBL] [Abstract][Full Text] [Related]
16. [Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].
Saint-André JP; Berger-Dutrieux N; Le Bodic MF; de Micco C; Trouillas J
Arch Anat Cytol Pathol; 1994; 42(2):77-82. PubMed ID: 7811118
[TBL] [Abstract][Full Text] [Related]
17. Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene.
Montag AG; Oka T; Baek KH; Choi CS; Jay G; Agarwal K
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6696-700. PubMed ID: 8393573
[TBL] [Abstract][Full Text] [Related]
18. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
[TBL] [Abstract][Full Text] [Related]
19. The gonadotropin-releasing hormone receptor gene promoter directs pituitary-specific oncogene expression in transgenic mice.
Albarracin CT; Frosch MP; Chin WW
Endocrinology; 1999 May; 140(5):2415-21. PubMed ID: 10218996
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
